| 6.02 Data as of May 21 | +0.47 / +8.47%Today’s Change | 1.50 Today|||52-Week Range 11.60 | +54.36% Year-to-Date |
| SECTOR Finance | INDUSTRY Investment Banks/Brokers | MARKET CAP $29.8M |
Cellular Biomedicine Group, Inc. 530 University Avenue Palo Alto California 94301 |

| Wen Tao Liu, PhD | Chairman & Chief Executive Officer |
| Wei Cao, PhD | President, Chief Operating Officer & Director |
| Andrew Chan | Chief Financial Officer |